NCT02430870View on ClinicalTrials.gov

TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

TAK-648

TAK-648 solution

DRUG

Placebo

TAK-648 placebo-matching solution

Trial Locations (2)

Unknown

Anaheim

Chula Vista

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY